Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

8.40
-0.0300-0.36%
Volume:434.61K
Turnover:3.68M
Market Cap:1.53B
PE:-82.35
High:8.63
Open:8.49
Low:8.27
Close:8.43
52wk High:10.08
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.89
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-157.33
PE(LYR):2,619.27

Loading ...

Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 27, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Dec 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Sep 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report